Skip to main content
main-content

Zeitschrift

European Journal of Nuclear Medicine and Molecular Imaging

European Journal of Nuclear Medicine and Molecular Imaging 3/2020

Ausgabe 3/2020

Inhaltsverzeichnis ( 31 Artikel )

05.12.2019 | Book Review | Ausgabe 3/2020

ATLAS OF PET-CT, A Quick Guide to Image Interpretation

Stefano Fanti, Mohsen Farsad, Luigi Mansi, Paolo Castellucci Second Edition, Springer, 2018 ISBN 978-3-662-57742-4
Ignasi Carrió

01.03.2020 | Editorial | Ausgabe 3/2020

Radiology and nuclear medicine: advancing together in the era of precision medicine

Arturo Chiti, Yves Menu

05.12.2019 | Editorial | Ausgabe 3/2020

Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies

Frederik A. Verburg, Martha Hoffmann, Ioannis Iakovou, Mark W. Konijnenberg, Jasna Mihailovic, Pablo Minguez Gabina, Petra Petranović Ovčariček, Cristoph Reiners, Alexis Vrachimis, Slimane Zerdoud, Luca Giovanella, Markus Luster

04.09.2019 | Editorial | Ausgabe 3/2020

18F-FDG PET/CT in patients with post-transplant lymphoproliferative disorders: so far so good

Giorgio Treglia, Luca Ceriani

18.11.2019 | Letter to the Editor | Ausgabe 3/2020

Letter to the Editor: 18F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma

Paulo Schiavom Duarte

21.11.2019 | Letter to the Editor | Ausgabe 3/2020

18F-Fluoride (18F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines!

Giorgio Treglia, Luca Giovanella

24.08.2019 | Original Article | Ausgabe 3/2020 Open Access

Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield

F. M. Montes de Jesus, T. C. Kwee, X. U. Kahle, M. Nijland, T. van Meerten, G. Huls, R. A. J. O. Dierckx, S. Rosati, A. Diepstra, W. van der Bij, E. A. M. Verschuuren, A. W. J. M. Glaudemans, W. Noordzij

27.11.2019 | Original Article | Ausgabe 3/2020

Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT

Qingqing Pan, Xinxin Cao, Yaping Luo, Jian Li, Jun Feng, Fang Li

09.11.2019 | Original Article | Ausgabe 3/2020

Assessment of the impact of 2015 American Thyroid Association guidelines in management of differentiated thyroid cancer patients

Sayak Choudhury, Archi Agrawal, Gouri Pantvaidya, Sneha Shah, Nilendu Purandare, Ameya Puranik, Venkatesh Rangarajan

09.11.2019 | Original Article | Ausgabe 3/2020

Variations in radioiodine ablation: decision-making after total thyroidectomy

O. Maas, F. Forrer, M. Maas, C. M. Panje, J. Blautzik, M. Brühlmeier, I. Engel-Bicik, L. Giovanella, A. Haldemann, M. E. Kamel, S. Kneifel, C. Rottenburger, N. Schaefer, M. A. Walter, S. Weidner, P. M. Putora

10.12.2019 | Original Article | Ausgabe 3/2020

Clinicopathologic risk factors of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective cohort study

Seong Young Kwon, Sang-Woo Lee, Eun Jung Kong, Keunyoung Kim, Byung Il Kim, Jahae Kim, Heeyoung Kim, Seol Hoon Park, Jisun Park, Hye Lim Park, So Won Oh, Kyoung Sook Won, Young Hoon Ryu, Joon-Kee Yoon, Soo Jin Lee, Jong Jin Lee, Ari Chong, Young Jin Jeong, Ju Hye Jeong, Young Seok Cho, Arthur Cho, Gi Jeong Cheon, Eun Kyoung Choi, Jae Pil Hwang, Sang Kyun Bae, Korean Society of Nuclear Medicine (KSNM) Thyroid Cancer Clinical Trial Network (CTN) Retrospective Cohort Study Group

01.03.2020 | Original Article | Ausgabe 3/2020

Superior performance of 18F-fluorocholine digital PET/CT in the detection of parathyroid adenomas

Diego Alfonso López-Mora, Marina Sizova, Montserrat Estorch, Albert Flotats, Valle Camacho, Alejandro Fernández, Safae Abouzian, Francisco Fuentes-Ocampo, José Ignacio Pérez Garcia, Ana Isabel Chico Ballesteros, Joan Duch, Anna Domènech, Antonio Moral Duarte, Ignasi Carrió

11.12.2019 | Guidelines | Ausgabe 3/2020

[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0

Cristina Nanni, Lucia Zanoni, Tore Bach-Gansmo, Heikki Minn, Frode Willoch, Trond Velde Bogsrud, Ephraim Parent Edward, Bital Savir-Baruch, Eugene Teoh, Fenton Ingram, Stefano Fanti, David M. Schuster

14.11.2019 | Original Article | Ausgabe 3/2020

18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer

Christos Sachpekidis, A. Afshar-Oromieh, K. Kopka, D. S. Strauss, L. Pan, U. Haberkorn, A. Dimitrakopoulou-Strauss

07.12.2019 | Original Article | Ausgabe 3/2020

Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET/CT

Yu Zhao, Andrei Gafita, Bernd Vollnberg, Giles Tetteh, Fabian Haupt, Ali Afshar-Oromieh, Bjoern Menze, Matthias Eiber, Axel Rominger, Kuangyu Shi

02.12.2019 | Original Article | Ausgabe 3/2020

Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison

Ian Alberts, George Prenosil, Christos Sachpekidis, Thilo Weitzel, Kuangyu Shi, Axel Rominger, Ali Afshar-Oromieh

01.11.2019 | Original Article | Ausgabe 3/2020

68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer—a modified protocol compared with the common protocol

Fabian Haupt, Lotte Dijkstra, Ian Alberts, Christos Sachpekidis, Viktor Fech, Silvan Boxler, Tobias Gross, Tim Holland-Letz, Helle D. Zacho, Uwe Haberkorn, Kambiz Rahbar, Axel Rominger, Ali Afshar-Oromieh

15.11.2019 | Original Article | Ausgabe 3/2020

The effect of androgen deprivation therapy on 68Ga-PSMA tracer uptake in non-metastatic prostate cancer patients

Cem Onal, Ozan Cem Guler, Nese Torun, Mehmet Reyhan, Ali Fuat Yapar

01.03.2020 | Original Article | Ausgabe 3/2020

The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia

Ian Alberts, Christos Sachpekidis, Lotte Dijkstra, George Prenosil, Eleni Gourni, Silvan Boxler, Tobias Gross, George Thalmann, Kambiz Rahbar, Axel Rominger, Ali Afshar-Oromieh

04.12.2019 | Original Article | Ausgabe 3/2020

Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer

Daniela A. Ferraro, Helena I. Garcia Schüler, Urs J. Muehlematter, Daniel Eberli, Julian Müller, Alexander Müller, Roger Gablinger, Helmut Kranzbühler, Aurelius Omlin, Philipp A. Kaufmann, Thomas Hermanns, Irene A. Burger

26.12.2019 | Original Article | Ausgabe 3/2020 Open Access

Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer

Otto Ettala, Simona Malaspina, Terhi Tuokkola, Pauliina Luoto, Eliisa Löyttyniemi, Peter J. Boström, Jukka Kemppainen

01.03.2020 | Original Article | Ausgabe 3/2020 Open Access

The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer

Meghana Kulkarni, Simon Hughes, Andrew Mallia, Victoria Gibson, Jennifer Young, Ajay Aggarwal, Stephen Morris, Ben Challacombe, Rick Popert, Christian Brown, Paul Cathcart, Prokar Dasgupta, Victoria S. Warbey, Gary J. R. Cook

01.03.2020 | Short Communication | Ausgabe 3/2020

New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide

Florian Rosar, Sebastian Dewes, Martin Ries, Andrea Schaefer, Fadi Khreish, Stephan Maus, Hendrik Bohnenberger, Johannes Linxweiler, Mark Bartholomä, Carsten Ohlmann, Samer Ezziddin

27.11.2019 | Original Article | Ausgabe 3/2020 Open Access

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

Johanna Maffey-Steffan, Lorenza Scarpa, Anna Svirydenka, Bernhard Nilica, Christian Mair, Sabine Buxbaum, Jasmin Bektic, Elisabeth von Guggenberg, Christian Uprimny, Wolfgang Horninger, Irene Virgolini

28.11.2019 | Original Article | Ausgabe 3/2020 Open Access

Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks

Sazan Rasul, Marcus Hacker, Elisabeth Kretschmer-Chott, Asha Leisser, Bernhard Grubmüller, Gero Kramer, Shahrokh Shariat, Wolfgang Wadsak, Markus Mitterhauser, Markus Hartenbach, Alexander R. Haug

22.11.2019 | Original Article | Ausgabe 3/2020

225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience

Fadi Khreish, Niklas Ebert, Martin Ries, Stephan Maus, Florian Rosar, Hendrik Bohnenberger, Tobias Stemler, Matthias Saar, Mark Bartholomä, Samer Ezziddin

15.11.2019 | Short Communication | Ausgabe 3/2020

Planar scan vs. SPECT/low-dose CT for estimating split renal function by 99mTc-DMSA scintigraphy in children

Michala Holm Reichkendler, Ronan M. G. Berg, Robin de Nijs, Hanne Nørgaard, Ida Maria Schmidt, Lise Borgwardt

01.03.2020 | Image of the Month | Ausgabe 3/2020

Extranodal involvement of multiple organs in diffuse large B cell lymphoma detected on 18F-FDG PET/CT

Tianbin Song, Rong Rong, Yusheng Su, Zhigang Liang, Jie Lu

25.11.2019 | Image of the Month | Ausgabe 3/2020

Isolated involvement of thyroid gland by IgG4-related disease revealed by 18F-FDG PET/CT

Yuanyuan Jiang, Guozhu Hou, Wuying Cheng

18.11.2019 | Image of the Month | Ausgabe 3/2020 Open Access

Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy

Bart de Keizer, Kamil G. Laban, Rachel Kalmann

01.03.2020 | Correction | Ausgabe 3/2020

Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

Johanna Maffey-Steffan, Lorenza Scarpa, Anna Svirydenka, Bernhard Nilica, Christian Mair, Sabine Buxbaum, Jasmin Bektic, Elisabeth von Guggenberg, Christian Uprimny, Wolfgang Horninger, Irene Virgolini

Aktuelle Ausgaben